|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00690 UNI-BIO GROUP
Nominal 
0.097 -0.003 (-3.000%) | 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Turnover | 586,211 | 6.009% | 552,980 | 484,718 | 440,316 | 353,405 |
| Cost of Sales | (98,650) | 7.331% | (91,912) | (91,900) | (105,433) | (76,398) |
| Gross Profit | 487,561 | 5.746% | 461,068 | 392,818 | 334,883 | 277,007 |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | (2,307) | (15,610) | |
| Share of Results of Asso. & JCEs | 274 | -- | (1) | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 101,521 | 11.354% | 91,170 | 75,900 | 43,287 | (20,012) | |
| Taxation | (8,194) | -2.406% | (8,396) | (5,024) | (4,775) | 421 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 93,327 | 12.749% | 82,774 | 70,876 | 38,512 | (19,591) | |
| 2025/12 - Final HKD(K$) | %Chg (Compare to Final) | 2024/12 HKD(K$) | 2023/12 HKD(K$) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | |
| Net Finance Costs / (Income) | (1,552) | -28.215% | (2,162) | (567) | (921) | 6 |
| Depreciation & Amortisation | 19,091 | -10.581% | 21,350 | 16,882 | 17,546 | 20,850 |
| Directors' Emoluments | -- | -- | 5,500 | 3,259 | 3,081 | 4,540 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 1.560 | 15.556% | 1.350 | 1.110 | 0.610 | -0.310 |
| DPS (cts) | 0.313 | -- | 0.277 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 20.064% | -- | 20.519% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.011 | 0.016 | 0.008 | 0.002 |
| NBV per share ($) | 0.069 | -- | 0.055 | 0.040 | 0.031 | 0.027 |
| Remarks: | Real time quote last updated: 01/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 93,327 |
| %Change | 12.749% |
| EPS / (LPS) | HKD 0.016 |
| NBV Per Share ($) | HKD 0.069 |